0 followers
Operator of a covalent drug discovery company intended to create novel therapeutics by using covalency to imprint and regulate proteins. The company applies cutting-edge capabilities and expertise in chemistry, quantitative proteomics, translational sciences, and deep learning, enabling clients to t... Read more
Ivan Cornella-Taracido
This company has no teams yet